Dr. Lianhai Zhang 张连海
Chief Physician, Associate Professor
Gastrointestinal Tumor Center, Ward 1, Peking University Cancer Hospital, Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and treatment of common abdominal tumors, primarily gastric and intestinal cancers.
Dr. Zhang holds a Doctorate in Surgery and serves as Chief Physician and Associate Professor. Since late 2002, Dr. Zhang has worked in surgical oncology and basic research at Peking University Cancer Hospital, also helping manage the tumor biobank. Research focuses on molecular markers for digestive tract tumor prognosis and drug sensitivity in mouse xenograft models.
Professional roles
- Youth Committee Member, Gastric Cancer Professional Committee, China Anti-Cancer Association
- Corresponding Editorial Board Member, Chinese Journal of Gastroenterology
Name order: in Chinese the family name comes first (Zhang Lianhai). Papers usually list the name as Lianhai Zhang or Zhang L.
Selected publications
112 papers on PubMed matched by name and affiliation; 2 as first or senior author since 2016. Most recent first- or senior-author papers:
- Biopreserv Biobank, 2026 (first author): Tumor-Derived Model Biobanks in China: Current Status and Future Challenges. PubMed 42557540
- Anticancer Res, 2023 (senior author): Targeting SALL4 by Entinostat Inhibits the Malignant Phenotype of Gastric Cancer Cells by Reducing EMT Signaling. PubMed 37772555
- Sci Rep, 2015 (first author): The extent of inflammatory infiltration in primary cancer tissues is associated with lymphomagenesis in immunodeficient mice. PubMed 25819560
- Biopreserv Biobank, 2015 (first author): Establishment of a network-based intra-hospital virtual cancer biobank. PubMed 25686047
- Zhonghua Wei Chang Wai Ke Za Zhi, 2015 (first author): [Biobank in the age of big data]. PubMed 25656021
- Zhonghua Wei Chang Wai Ke Za Zhi, 2013 (first author): [Prognostic biomarkers and targeted therapies for gastric cancer]. PubMed 23446485
- J Cancer Res Clin Oncol, 2006 (first author): Dominant expression of 85-kDa form of cortactin in colorectal cancer. PubMed 16261345
- World J Gastroenterol, 2005 (first author): Molecular profiling of hepatocellular carcinomas by cDNA microarray. PubMed 15641127
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion